← FDA Drug Approvals (Drugs@FDA)

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2014-09-08

Drug application

FDA Application #

ANDA091149

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Generic name

Buprenorphine Hydrochloride

Active ingredients

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Dosage form

TABLET

Route

SUBLINGUAL

Marketing status

Discontinued

Sponsor

TEVA PHARMS USA

First approval

2014-09-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown